YMAB
Y-mAbs Therapeutics
YMAB
YMAB
Delisted
YMAB was delisted on the 15th of September, 2025.
95 hedge funds and large institutions have $374M invested in Y-mAbs Therapeutics in 2024 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 25 increasing their positions, 44 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7% less call options, than puts
Call options by funds: $748K | Put options by funds: $808K
43% less repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 44
Holders
95
Holding in Top 10
1
Calls
$748K
Puts
$808K
Top Buyers
| 1 | +$36.3M | |
| 2 | +$24.8M | |
| 3 | +$12.1M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$6.73M |
| 5 |
Millennium Management
New York
|
+$4.25M |
Top Sellers
| 1 | -$7.5M | |
| 2 | -$5.65M | |
| 3 | -$4.91M | |
| 4 |
D.E. Shaw & Co
New York
|
-$4.16M |
| 5 |
Los Angeles Capital Management
Los Angeles,
California
|
-$3.72M |